Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 3Terminated 2Withdrawn 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 9Rectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 8Squamous Cell Carcinoma of Head and Neck 6Uterine Cervical Neoplasms 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 4Glioblastoma 4Esophageal Neoplasms 4Brain Neoplasms 4Neoplasms 3Nasopharyngeal Carcinoma 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Colorectal Neoplasms 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma 2Adenocarcinoma 2Spinal Cord Neoplasms 1Small Cell Lung Cancer Extensive Stage 1Sarcoma 1Rhabdomyosarcoma 1Rectal Cancer Patients 1Radiation Injuries 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pelvic Neoplasms 1

Interventions

Cyclophosphamide 6fludarabine 5Rituximab 4obinutuzumab 3tafasitamab 2relmacabtagene autoleucel 2pirtobrutinib 2zanubrutinib 1venetoclax 1tisagenlecleucel 1resiniferatoxin 1pomalidomide 1polatuzumab vedotin 1glofitamab 1Vincristine 1Tretinoin 1Surveys and Questionnaires 1Specimen Handling 1Radiotherapy 1Prednisolone 1Magnetic Resonance Spectroscopy 1Interleukin-2 1Immunotherapy, Adoptive 1Immune Checkpoint Inhibitors 1Doxorubicin 1Dexamethasone 1Blood Specimen Collection 1Bendamustine Hydrochloride 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Lymphoma, B-Cell × Radiotherapy × Clear all
NCT06646666 2024-11-01

ARTA-based Chemo-free Bridging/Maintenance Therapy in CAR-T Treatment for High-Risk R/R B-NHL Ineligible for HDCT and ASCT

Ruijin Hospital

Phase 2 Not yet recruiting
35 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡